<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01598532</url>
  </required_header>
  <id_info>
    <org_study_id>2009-P-001552</org_study_id>
    <nct_id>NCT01598532</nct_id>
  </id_info>
  <brief_title>Effects of LEDs on Memory in TBI Patients</brief_title>
  <acronym>LED</acronym>
  <official_title>Treatment of Cognitive Dysfunction in Mild TBI With Transcranial Light Emitting Diodes- An Open Protocol, Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spaulding Rehabilitation Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Spaulding Rehabilitation Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to investigate whether transcranial, high-intensity LED placed on
      the scalp can improve working memory in people who have sustained a concussion with lingering
      effects or a mild brain injury.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a four month, outpatient, single center study investigating whether transcranial,
      high intensity LED applied outside the skull can improve frontal lobe executive function and
      working memory in participants with chronic, mild Traumatic Brain Injury (TBI), with or
      without mild posttraumatic stress disorder (PTSD), due to closed head injury.

      Participants will sign the Informed Consent Form(ICF) before Neuropsychological Screening
      test are administered. If the participant's neuropsychological screening test scores meet the
      Inclusion/Exclusion criteria and the participant meets the other Inclusion/Exclusion
      criteria, then he/she will be tested again on the tests that are part of the
      Neuropsychological Outcome Measures, the week before the Transcranial LED treatments, and
      during the week after the last LED treatment and again at one and two months after the last
      LED treatment. Treatment with Transcranial LED will be for 6 weeks. Participants will be
      treated three times per week: Monday, Wednesday and Friday. A total of 18 Transcranial LED
      treatments will be administered.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stroop Test for Executive Function - Trial 3 - Inhibition</measure>
    <time_frame>Baseline and 1-Week, 1-month and 2-months after final LED Treatment</time_frame>
    <description>Stroop Test for Executive Function - Trial 3 (D-KEFS) - Inhibition measures executive function, inhibition that has been converted to Z-score, # of Standard Deviation units. Higher Mean scores equals better outcomes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stroop Test for Executive Function - Trial 4 Inhibition Switching</measure>
    <time_frame>Baseline and 1-Week, 1-Month and 2-Months after the Final LED Treatment</time_frame>
    <description>Stroop Test for Executive Function - Trial 4 (D-KEFS) Inhibition Switching that has been converted to Z-score, # of Standard Deviation units. Higher Mean scores equals better outcomes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>California Verbal Learning Test-II (CVLT-II) Total, Trials 1-5</measure>
    <time_frame>Baseline and 1-Week, 1-Month and 2-Months after Final LED Treatment</time_frame>
    <description>California Verbal Learning Test-II (CVLT-II) Total, Trials 1 - 5 measures word recall on trials 1-5 that has been converted to Z-score, # of Standard Deviation units. Higher Mean scores equals better outcomes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>California Verbal Learning Test-II (CVLT-II) Long Delay Free Recall</measure>
    <time_frame>Baseline and 1-Week, 1-Month and 2-Months after final LED Treatment</time_frame>
    <description>California Verbal Learning Test-II (CVLT-II) Long Delay Free Recall measures word recall after a 20 minute delay that has been converted to Z-score, # of Standard Deviation units. Higher Mean scores equals better outcomes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Controlled Oral Word Association Test (FAS)</measure>
    <time_frame>Baseline and 1-Week, 1-Month and 2-Months after final LED Treatment</time_frame>
    <description>Controlled Oral Word Association Test (FAS) measures verbal fluency that has been converted to Z-score, # of Standard Deviation units. Higher Mean scores equals better outcomes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Digit Span, Forwards and Backwards</measure>
    <time_frame>Baseline and 1-Week, 1-Month and 2-Months after final LED Treatment</time_frame>
    <description>Digit Span, Forwards and Backwards measures short-term auditory memory and working memory that has been converted to Z-score, # of Standard Deviation units. Higher Mean scores equals better outcomes.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <arm_group>
    <arm_group_label>Transcranial LED Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All study subjects received treatment during 6-Week period (3x per week) for a total of 18 Transcranial LED Treatments using the MedX Health Phototherapy (light). Each session was 30 minutes in duration.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MedX Health Phototherapy (light therapy)</intervention_name>
    <description>The treatment period is 6 weeks (3x per week) for a total of 18 Transcranial LED treatments. Each treatment session is 30 minutes each.</description>
    <arm_group_label>Transcranial LED Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female, Ages 18-65

          -  sustained a mild traumatic brain injury(mTBI) at least 6 months ago

          -  mTBI is defined as &lt; 30 minutes loss of consciousness and &lt;30 minutes, post trauma
             amnesia

          -  since the injury patient continues having problems with memory and thinking ability

        Exclusion Criteria:

          -  Younger than 18 or older than 65

          -  mTBI occured less than 6 months ago

          -  moderate to severe Traumatic Brain Injury (TBI)

          -  non-closed head injury

          -  presence of craniotomy, craniectomy, or ventriculoperitoneal shunt

          -  Non-English speaking subjects - Neuropsychological Tests only in English

          -  Neuropsychological Screening Test Scores not at least 2 SD below norm on one of the
             neuropsychological tests or not 1 SD below norm on at least two of the tests
             administered during screening)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ross D Zafonte, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spaulding Rehabilitation Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Spaulding Rehabilitation Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://pmr.hms.harvard.edu/pages/10/119/</url>
    <description>Department of Physical Medicine and Rehabilitation at Spaulding Hospital - Research</description>
  </link>
  <results_reference>
    <citation>Hashmi JT, Huang YY, Osmani BZ, Sharma SK, Naeser MA, Hamblin MR. Role of low-level laser therapy in neurorehabilitation. PM R. 2010 Dec;2(12 Suppl 2):S292-305. doi: 10.1016/j.pmrj.2010.10.013. Review.</citation>
    <PMID>21172691</PMID>
  </results_reference>
  <results_reference>
    <citation>Naeser MA, Saltmarche A, Krengel MH, Hamblin MR, Knight JA. Improved cognitive function after transcranial, light-emitting diode treatments in chronic, traumatic brain injury: two case reports. Photomed Laser Surg. 2011 May;29(5):351-8. doi: 10.1089/pho.2010.2814. Epub 2010 Dec 23.</citation>
    <PMID>21182447</PMID>
  </results_reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2012</study_first_submitted>
  <study_first_submitted_qc>May 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2012</study_first_posted>
  <results_first_submitted>May 16, 2016</results_first_submitted>
  <results_first_submitted_qc>July 12, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 22, 2016</results_first_posted>
  <last_update_submitted>August 23, 2016</last_update_submitted>
  <last_update_submitted_qc>August 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Spaulding Rehabilitation Hospital</investigator_affiliation>
    <investigator_full_name>Ross D. Zafonte, MD</investigator_full_name>
    <investigator_title>Vice President Medical Affairs, Research and Education Spaulding Rehabilitation Network</investigator_title>
  </responsible_party>
  <keyword>mild traumatic brain injury</keyword>
  <keyword>mild TBI</keyword>
  <keyword>mTBI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment for the study began in April 2010. Potential subjects were recruited through several different methods - Spaulding Rehabilitation Hospital outpatient clinic, advertisements in local area newspapers, Brain Injury Association of MA and other area organizations that provide services to TBI survivors, flyers, on-line and social media.</recruitment_details>
      <pre_assignment_details>22 study subjects signed the consent but only 11 completed the study. The 11 that did not completed the study either did not meet the inclusion criteria at Screening or were lost to follow-up after they screened for the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Transcranial LED Treatment</title>
          <description>Population was Males and Females, ages 18 to 65 years who sustained a mild traumatic brain injury at least 6 months prior to study participation. All study subjects received treatment during 6-Week period (3x per week) for a total of 18 Transcranial LED Treatments using the MedX Health Phototherapy (light). Each session was 30 minutes in duration.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Did not meet inclusion criteria</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Population was Males and Females, ages 18 to 65 years who sustained a mild traumatic brain injury at least 6 months prior to study participation</population>
      <group_list>
        <group group_id="B1">
          <title>Transcranial LED Treatment</title>
          <description>All study subjects received LED treatment during 6-Week period (3x per week) for a total of 18 Transcranial LED Treatments using the MedX Health Phototherapy. Each session was 30 minutes in duration. Neuropsychological testing was administered at the following time points: within 1 week of the first LED treatment and within 1 week, 1 month &amp; 2 months following the last LED treatment.
The neuropsychological testing included: 1)Stroop test, 2) California Verbal Learning Test-II (CVLT- II), Short Delay Free &amp; Cued Recall, Long Delay Free &amp; Cued Recall, 3) Delis-Kaplan Executive Function (D-KEF) -Trails Test, 4) Controlled Oral Word Association Test (FAS), &amp; 5) Digit Span, Forwards &amp; Backwards.
The following tests were not analyzed due to collinearity with other measures (r &gt; .8): Short Delay Free &amp; Cued Recall, Long Delay Cued Recall, &amp; Delis-Kaplan Executive Function (D-KEF) -Trails Test.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Time Post TBI</title>
          <description>This calculates the time elapsed since injury</description>
          <units>years post TBI</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.12" spread="2.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Years of Education</title>
          <description>Numbers of years of education</description>
          <units>Years of Education</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15.72" spread="2.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Stroop Test for Executive Function - Trial 3 - Inhibition</title>
        <description>Stroop Test for Executive Function - Trial 3 (D-KEFS) - Inhibition measures executive function, inhibition that has been converted to Z-score, # of Standard Deviation units. Higher Mean scores equals better outcomes.</description>
        <time_frame>Baseline and 1-Week, 1-month and 2-months after final LED Treatment</time_frame>
        <population>All participants enrolled in the Transcranial LED Treatment Group</population>
        <group_list>
          <group group_id="O1">
            <title>Transcranial LED Treatment</title>
            <description>MedX Health Phototherapy (light therapy): The treatment period is 6 weeks (3x per week) for a total of 18 Transcranial LED treatments. Each treatment session is 30 minutes each.</description>
          </group>
        </group_list>
        <measure>
          <title>Stroop Test for Executive Function - Trial 3 - Inhibition</title>
          <description>Stroop Test for Executive Function - Trial 3 (D-KEFS) - Inhibition measures executive function, inhibition that has been converted to Z-score, # of Standard Deviation units. Higher Mean scores equals better outcomes.</description>
          <population>All participants enrolled in the Transcranial LED Treatment Group</population>
          <units># of SD units</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7407" spread="1.1561"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Week post test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".036" spread=".7407"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Month post test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".718" spread="1.0133"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 Months post test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".815" spread=".9499"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>linear trend over time for the effect of LED treatments</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.004</p_value>
            <method>ANOVA</method>
            <method_desc>Univariate, one-way, repeated measure ANOVA with trend analysis</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Stroop Test for Executive Function - Trial 4 Inhibition Switching</title>
        <description>Stroop Test for Executive Function - Trial 4 (D-KEFS) Inhibition Switching that has been converted to Z-score, # of Standard Deviation units. Higher Mean scores equals better outcomes.</description>
        <time_frame>Baseline and 1-Week, 1-Month and 2-Months after the Final LED Treatment</time_frame>
        <population>All participants enrolled in Transcranial LED Treatment Group</population>
        <group_list>
          <group group_id="O1">
            <title>Transcranial LED Treatment</title>
            <description>Population was Males and Females, ages 18 to 65 years who sustained a mild traumatic brain injury at least 6 months prior to study participation. All study subjects received treatment during 6-Week period (3x per week) for a total of 18 Transcranial LED Treatments using the MedX Health Phototherapy (light). Each session was 30 minutes in duration.</description>
          </group>
        </group_list>
        <measure>
          <title>Stroop Test for Executive Function - Trial 4 Inhibition Switching</title>
          <description>Stroop Test for Executive Function - Trial 4 (D-KEFS) Inhibition Switching that has been converted to Z-score, # of Standard Deviation units. Higher Mean scores equals better outcomes.</description>
          <population>All participants enrolled in Transcranial LED Treatment Group</population>
          <units># of SD Units</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.050" spread="1.1058"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 week post test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.100" spread="1.3994"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Month post test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".553" spread="1.167"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 Month post test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".854" spread="1.3544"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>linear trend over time for the effect of LED treatments</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.003</p_value>
            <method>ANOVA</method>
            <method_desc>Univariate, one-way, repeated measure ANOVA with trend analysis</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>California Verbal Learning Test-II (CVLT-II) Total, Trials 1-5</title>
        <description>California Verbal Learning Test-II (CVLT-II) Total, Trials 1 - 5 measures word recall on trials 1-5 that has been converted to Z-score, # of Standard Deviation units. Higher Mean scores equals better outcomes.</description>
        <time_frame>Baseline and 1-Week, 1-Month and 2-Months after Final LED Treatment</time_frame>
        <population>All participants enrolled in Real Intervention Group</population>
        <group_list>
          <group group_id="O1">
            <title>Transcranial LED Treatment</title>
            <description>Population was Males and Females, ages 18 to 65 years who sustained a mild traumatic brain injury at least 6 months prior to study participation. All study subjects received treatment during 6-Week period (3x per week) for a total of 18 Transcranial LED Treatments using the MedX Health Phototherapy (light and laser). Each session was 30 minutes in duration.</description>
          </group>
        </group_list>
        <measure>
          <title>California Verbal Learning Test-II (CVLT-II) Total, Trials 1-5</title>
          <description>California Verbal Learning Test-II (CVLT-II) Total, Trials 1 - 5 measures word recall on trials 1-5 that has been converted to Z-score, # of Standard Deviation units. Higher Mean scores equals better outcomes.</description>
          <population>All participants enrolled in Real Intervention Group</population>
          <units># of SD Units</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-test Data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.409" spread=".7687"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Week post test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".364" spread=".809"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Month post test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".630" spread=".7015"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 Month post test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".780" spread=".9724"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>linear trend over time for effect of LED treatments</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.003</p_value>
            <method>ANOVA</method>
            <method_desc>Univariate, one-way, repeated measure ANOVA with trend analysis</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>California Verbal Learning Test-II (CVLT-II) Long Delay Free Recall</title>
        <description>California Verbal Learning Test-II (CVLT-II) Long Delay Free Recall measures word recall after a 20 minute delay that has been converted to Z-score, # of Standard Deviation units. Higher Mean scores equals better outcomes.</description>
        <time_frame>Baseline and 1-Week, 1-Month and 2-Months after final LED Treatment</time_frame>
        <population>All participants enrolled in Transcranial LED Treatment Group</population>
        <group_list>
          <group group_id="O1">
            <title>Transcranial LED Treatment</title>
            <description>Population was Males and Females, ages 18 to 65 years who sustained a mild traumatic brain injury at least 6 months prior to study participation. All study subjects received treatment during 6-Week period (3x per week) for a total of 18 Transcranial LED Treatments using the MedX Health Phototherapy (light). Each session was 30 minutes in duration.</description>
          </group>
        </group_list>
        <measure>
          <title>California Verbal Learning Test-II (CVLT-II) Long Delay Free Recall</title>
          <description>California Verbal Learning Test-II (CVLT-II) Long Delay Free Recall measures word recall after a 20 minute delay that has been converted to Z-score, # of Standard Deviation units. Higher Mean scores equals better outcomes.</description>
          <population>All participants enrolled in Transcranial LED Treatment Group</population>
          <units># of SD Units</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.136" spread="1.4334"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Week post test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.136" spread="1.1851"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Month post test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.200" spread="1.249"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 Month post test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.050" spread="1.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>linear trend over time for the effects of LED treatments</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.006</p_value>
            <method>ANOVA</method>
            <method_desc>Univariate, one-way, repeated measure ANOVA with trend analysis</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Controlled Oral Word Association Test (FAS)</title>
        <description>Controlled Oral Word Association Test (FAS) measures verbal fluency that has been converted to Z-score, # of Standard Deviation units. Higher Mean scores equals better outcomes.</description>
        <time_frame>Baseline and 1-Week, 1-Month and 2-Months after final LED Treatment</time_frame>
        <population>All participants enrolled in the Transcranial LED Treatment Group</population>
        <group_list>
          <group group_id="O1">
            <title>Transcranial LED Treatment</title>
            <description>All study subjects received treatment during 6-Week period (3x per week) for a total of 18 Transcranial LED Treatments using the MedX Health Phototherapy (light). Each session was 30 minutes in duration.
MedX Health Phototherapy (light therapy): The treatment period is 6 weeks (3x per week) for a total of 18 Transcranial LED treatments. Each treatment session is 30 minutes each.</description>
          </group>
        </group_list>
        <measure>
          <title>Controlled Oral Word Association Test (FAS)</title>
          <description>Controlled Oral Word Association Test (FAS) measures verbal fluency that has been converted to Z-score, # of Standard Deviation units. Higher Mean scores equals better outcomes.</description>
          <population>All participants enrolled in the Transcranial LED Treatment Group</population>
          <units># of SD units</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.318" spread="1.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Week post test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".136" spread="1.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Month post test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".114" spread="1.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 Month post test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".285" spread="1.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Digit Span, Forwards and Backwards</title>
        <description>Digit Span, Forwards and Backwards measures short-term auditory memory and working memory that has been converted to Z-score, # of Standard Deviation units. Higher Mean scores equals better outcomes.</description>
        <time_frame>Baseline and 1-Week, 1-Month and 2-Months after final LED Treatment</time_frame>
        <population>All participants enrolled in the Transcranial LED Treatment Group</population>
        <group_list>
          <group group_id="O1">
            <title>Transcranial LED Treatment</title>
            <description>Population was Males and Females, ages 18 to 65 years who sustained a mild traumatic brain injury at least 6 months prior to study participation. All study subjects received treatment during 6-Week period (3x per week) for a total of 18 Transcranial LED Treatments using the MedX Health Phototherapy (light). Each session was 30 minutes in duration.</description>
          </group>
        </group_list>
        <measure>
          <title>Digit Span, Forwards and Backwards</title>
          <description>Digit Span, Forwards and Backwards measures short-term auditory memory and working memory that has been converted to Z-score, # of Standard Deviation units. Higher Mean scores equals better outcomes.</description>
          <population>All participants enrolled in the Transcranial LED Treatment Group</population>
          <units># of SD units</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.182" spread="1.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Week post test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".318" spread="1.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Month post test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".444" spread="1.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 Month post test data</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".650" spread="1.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Over a period of 2 years 11 participants were studied with no adverse events</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Transcranial LED Treatment</title>
          <description>Population was Males and Females, ages 18 to 65 years who sustained a mild traumatic brain injury at least 6 months prior to study participation. All study subjects received treatment during 6-Week period (3x per week) for a total of 18 Transcranial LED Treatments using the MedX Health Phototherapy (light and laser). Each session was 30 minutes in duration.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Small sample size &amp; Open Protocol</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Ross D. Zafonte, DO</name_or_title>
      <organization>Spaulding Rehabilitation Hospital</organization>
      <phone>617-952-5227</phone>
      <email>rzafonte@partners.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

